Skip to main content
LYRA logo
LYRA
(NASDAQ)
Lyra Therapeutics, Inc.
$0.70-- (--)
Loading... - Market loading

Lyra Therapeutics (LYRA) Stock Price & Financial Analysis

Lyra Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.70 - $0.75
52-Week High$37.50
52-Week Low$0.31
Open$0.70
Volume3.15K
Average Volume (3M)10.31K
Market Cap10.87M
Shares Outstanding15.53M
Price to Sales (P/S)27.32
Price to Book (P/B)-1.01
EV/EBITDA-0.89
Revenue (TTM)398.00K
Net Income (TTM)-28.92M
Free Cash Flow (TTM)-28.98M
EPS (TTM)$-5.79
Profit Margin-7266.08%
Operating Margin-7425.38%
50-Day MA$0.74
200-Day MA$3.74
52-Week Change-84.31%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lyra Therapeutics

What is the current stock price for LYRA?

As of the latest trading session, LYRA stock trades at $0.70. The 52-week range is $0.31–$37.50, with a day range of $0.70–$0.75.

What is the P/E ratio for LYRA?

The P/E ratio (Price-to-Earnings) for LYRA is shown in the Key Statistics section. This valuation metric helps compare Lyra Therapeutics, Inc. to industry peers.

Does LYRA pay dividends?

Lyra Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LYRA?

Analyst ratings and recommendations for LYRA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of LYRA?

Lyra Therapeutics's market capitalization is $10.9M, classifying it as a micro-cap company. Lyra Therapeutics operates in the Healthcare sector within the Biotechnology industry.